EXTRACORPOREAL IMPLANT CONTROLLERS

• US 20160206890A1
• Filed: 01/21/2015
• Published: 07/21/2016
• Est. Priority Date: 01/21/2015
• Status: Active Grant

• Current Assignee: BlueWind Medical Ltd.
• Original Assignee: BlueWind Medical Ltd.
• Inventors: ORON, Guri, BENJAMIN, Eran, PLOTKIN, Anton, GROSS, Yossi
• Granted Patent: US 9,764,146 B2
• Time in Patent Office: Days
• US Class Current: 1/1
• CPC Class Codes: A61N 1/36071 Pain
• CPC Class Codes: A61N 1/36125 Details of circuitry or electric components
• CPC Class Codes: A61N 1/37205 Microstimulators, e.g. implantable through a cannula
• CPC Class Codes: A61N 1/37229 Shape or location of the implanted or external antenna
• CPC Class Codes: A61N 1/3787 from an external energy source

Abstract

Apparatus, comprising (1) a first controller comprising at least one first-controller antenna configured to transmit a first wireless power signal having a first signal power; and a first-controller control unit configured to use battery power to drive the first-controller antenna; (2) a second controller, comprising at least one second-controller antenna, configured to transmit a second wireless power signal having a second signal power; and a second-controller control unit, configured to use mains electricity power to drive the second-controller antenna; and (3) an implant, comprising one or more electrodes; at least one implant antenna configured to receive 1-10 percent of the first signal power, and to receive 0.01-1 percent of the second signal power; and circuitry configured to drive the one or more electrodes responsively to the received 1-10 percent of the first signal power, or the received 0.01-1 percent of the second signal power.

Claims

1. Apparatus for treating a condition of a subject, the apparatus comprising:

a first controller, having a mass of 10-500 g and a volume of 25-250 cm̂

3, and comprising;

at least one first-controller antenna configured to transmit a first wireless power signal having a first signal power;

a battery configured to store battery power;

a first-controller control unit configured to use the battery power to drive the first-controller antenna to transmit the first wireless power signal;

a user input device, operable by the subject to power the first-controller control unit using the battery; and

a second controller, comprising;

at least one second-controller antenna, configured to transmit a second wireless power signal having a second signal power;

a mains electricity connector; and

a second-controller control unit, configured to use power from the mains electricity connector to drive the second-controller antenna to transmit the second wireless power signal; and

an implant, configured to be implanted in tissue of the subject, the implant comprising;

one or more tissue-contacting electrodes, configured to be placed in contact with the tissue;

at least one implant antenna configured to receive 1-10 percent of the first signal power of the first wireless power signal, and to receive 0.01-1 percent of the second signal power of the second wireless power signal; and

circuitry configured (i) to be powered by the received 1-10 percent of the first signal power, and to responsively drive the one or more electrodes to apply a current, and (ii) to be powered by the received 0.01-1 percent of the second signal power, and to responsively drive the one or more electrodes to apply the current.

3. The apparatus according to claim 1, wherein the first controller is capable, on a single charge of the battery, to drive the first-controller antenna to transmit the first wireless power signal for a total wireless power transmission time that is less than 3 hours.

4. The apparatus according to claim 1, wherein the implant does not comprise a non-transient power storage element.

5. The apparatus according to claim 1, wherein:

the implant comprises a sensor,

the circuitry is configured to power the sensor responsively to the power received by the implant antenna,

the sensor is configured to, when powered by the circuitry responsively to the power received by the implant antenna, detect a factor related to the condition of the subject, and

the circuitry is further configured to receive a signal from the sensor, and drive the one or more electrodes to apply the current at least in part responsively to the power received by the implant antenna, and at least in part responsively to the received signal.

6. The apparatus according to claim 1, wherein the first controller is a hand-held controller.

7. The apparatus according to claim 1, wherein the implant is injectable, and has a longitudinal axis and a cross-sectional area, transverse to the longitudinal axis, of 0.5-3 mm̂

2.

11. The apparatus according to claim 1, wherein the circuitry of the implant is configured, in response to receiving the first wireless power signal, to transmit a juxtaposition signal that includes information indicative of a juxtaposition between the implant and the first controller.

12. The apparatus according to claim 11, wherein the apparatus is for use with a cellphone, and:

the at least one first-controller antenna comprises a cellphone-interfacing antenna configured to communicate with the cellphone,

the juxtaposition signal is a first juxtaposition signal, and

the first controller is configured to receive the first juxtaposition signal, and to responsively drive the cellphone-interfacing antenna to transmit a second juxtaposition signal that includes information indicative of the juxtaposition between the implant and the first controller, and (ii) is receivable by the cellphone.

13. The apparatus according to claim 1, wherein the implant antenna is configured to receive the 1-10 percent of the first signal power while (i) the implant is implanted in the tissue, (ii) the first controller is disposed against skin of the subject directly superficially to the implant, and (iii) the first-controller control unit drives the first-controller antenna to transmit the first wireless power signal.

14. The apparatus according to claim 13, wherein the implant antenna is configured to receive the 0.01-1 percent of the second signal power while (i) the implant is implanted in the tissue, (ii) the subject is lying on a bed in which the second controller is disposed, and (iii) the second-controller control unit drives the second-controller antenna to transmit the second wireless power signal.

15. The apparatus according to claim 1, wherein the second-controller control unit has a longest period of power transmission with no user input, that is at least 1 hour.

16. The apparatus according to claim 15, wherein the second-controller control unit has a longest period of power transmission with no user input, that is at least 2 hours.

17. The apparatus according to claim 15, wherein the first-controller control unit has a longest period of power transmission with no user input, that is less than 1 hour.

18. The apparatus according to claim 17, wherein the first-controller control unit has a longest period of power transmission with no user input, that is less than 10 min.

19. The apparatus according to claim 1, wherein the first controller is incapable of powering the implant when a distance between the first-controller antenna and the implant antenna is greater than 10 cm.

20. The apparatus according to claim 19, wherein the second controller is capable of powering the implant when a distance between the second-controller antenna and the implant antenna is greater than 20 cm.

23. The apparatus according to claim 1,

wherein the first controller and the second controller are configured to communicate therebetween information regarding a transmission of wireless power selected from the group consisting of:

a transmission of the first wireless power signal, and a transmission of the second wireless power signal.

24. The apparatus according to claim 23, wherein the second controller is configured to configure at least one transmission of the second wireless power signal responsively to receiving, from the first controller, information regarding at least one transmission of the first wireless power signal.

2. (canceled)

8-10. -10. (canceled)

21-22. -22. (canceled)

25. A method for use with a subject that benefits from application of an electric current to a tissue site, the method comprising:

during a sleeping period in which the subject is sleeping, applying the current to the tissue site for a first proportion of the sleeping period; and

during a wakeful period in which the subject is awake, the wakeful period extending from the sleeping period to an immediately-subsequent sleeping period, applying the current to the tissue site for a second proportion of the wakeful period that is greater than zero and less than one-third of the first proportion,

wherein the wakeful period is a period during which the subject would benefit more from (a) applying the current to the tissue site for a third proportion of the wakeful period that is greater than two-thirds of the first proportion, than from (b) applying the current to the tissue site for the second proportion of the wakeful period.

26. A method for use with a subject suffering from a condition that benefits from application of electric current to a tissue site, the method comprising:

during a sleeping period in which the subject is sleeping, applying a first amount of energy to the tissue site by applying electric current to the tissue site; and

during a wakeful period in which the subject is awake, applying a second amount of energy by applying electric current to the tissue site, the second amount of energy being greater than zero and less than one-third of the first amount of energy, wherein the wakeful period (i) is defined as an entire period between the sleeping period and an immediately subsequent sleeping period, and (ii) is a period during which the condition would benefit more from applying a third amount of energy by applying electric current to the tissue site that is greater than two-thirds of the first amount of energy, than from applying the second amount of energy current to the tissue site by applying electric current.

27. A method for use with an implant implanted in tissue of a subject, the method comprising:

during a sleeping period in which the subject is sleeping, wirelessly powering the implant to apply an electric current to the tissue by wirelessly transmitting power using a mains-powered controller while the mains-powered controller is connected to mains electricity; and

during a wakeful period in which the subject is awake, wirelessly powering the implant to apply an electric current to the tissue by wirelessly transmitting power using a battery-powered controller while the battery-powered controller is powered by a battery and is not connected to mains electricity.

28-96. -96. (canceled)